Abstract:Objective To observe the effects of 99Tc Methylene Diphosphonate Injection on postoperative prognosis and quality of life after neurosurgery. Methods From December 2015 to February 2016, in Sanbo Brain Hospital, 80 patients underwent neurosurgery were selected, they were divided into 99Tc Methylene Diphosphonate Injection group and control group by random number table method, with 40 cases in each group. 99Tc Methylene Diphosphonate Injection group were given intravenously 4 sets of 99Tc Methylene Diphosphonate Injection after anesthetic induction and successive 4 d daily after surgery, control group were given the same volume of saline. Index of anesthesia recovery period, pain intensity, fatigue, degree of comfort, subsided time of head and facial edema, drainage time, time of suture removal and time of discharge were assessed after surgery were recorded. Results The pain scores of patients in 99Tc Methylene Diphosphonate Injection group from the 1st day to the morning of 5th day were lower than control group, the differences were statistically significant (P < 0.05). The weary degree in 99Tc Methylene Diphosphonate Injection group from 1st to 3rd day were lower than control group, comfort degree in 99Tc Methylene Diphosphonate Injection group were high than control group, the differences were statistically significant (P < 0.05). The sitting up time, leaving bed activity time, independent walk time and taking out stitchesand, discharge time in two groups were compared, the differences were not statistically significant (P > 0.05), The edema time of head and face and drainage time in 99Tc Methylene Diphosphonate Injection group were shorter than control group, the differences were statistically significant (P < 0.05). Conclusion The application of 99Tc Methylene Diphosphonate Injection in patients experiencing craniotomy can obviously increase the degree of comfort, improve appetite, relieve fatigue and postoperative pain, accelerate edema recession, and improve the quality of life after neurosurgery.
韩书勤 赵琳 胡适 王保国▲. 99Tc亚甲基二膦酸盐对神经外科患者术后转归及生活质量的影响[J]. 中国医药导报, 2017, 14(24): 30-33.
HAN Shuqin ZHAO Lin HU Shi WANG Baoguo▲. Effect of 99Tc Methylene Diphosphonate Injection on postoperative prognosis and quality of life after neurosurgery. 中国医药导报, 2017, 14(24): 30-33.
[1] Hans P,Deby C,Deby-Dupont G,Lamy M. Effect of propofol on in vitro lipid peroxidation induced by different free radical generating system: a comparison with vitamin E [J].J Neurosurg Anesthesiol,1996,8:154.
[2] 黄晓杰,黄建敏,解朋. 云克临床应用新进展[J].承德医学院学报,2015,32(4):341-344.
[3] 刘炳吉,于华,郑飞波,等.云克联合钙剂和维生素D3治疗原发性骨质疏松症疼痛的疗效及对骨密度的影响[J].中国全科医学,2012,15(10):3519-3521.
[4] 赵红,刘碧健.云克治疗类风湿关节炎的临床观察[J].医学信息,2015(14):70-71.
[5] 朱韶峰,付立武.云克联合甲基强的松龙治疗甲状腺相关性眼病的疗效观察[J].中国现代药物应用,2011,5(23):81-82.
[6] 杨俊.氯化锶(89Sr)、云克(99Tc-MDP)联合治疗多发性骨转移癌临床观察[J].医学信息,2015,28(4):132-133.
[7] 孙云闯,秦斌.MoCA和MMSE在轻度认识障碍中的应用比较[J].中国神经免疫学和神经病学杂志,2010,17(2):138-140.
[8] Husain K,Somani SM. Response of cardiac antioxidant system to alcohol and exercise training in the rat [J]. Alcohol,1997,14(3):301.
[9] Wang LM,Gu QR,Xu Y,et al. Effects of Yunke (technetium-99 conjugated with methylene diphosphonate 99Tc-MDP) and/or colloidal chromic phosphate phosphonium-32,alone and in combination,in rats with adjuvant arthritis[J]. Clin Exp Pharmacol Physiol,2008,35(1):23-28.
[10] 于云秀.依达拉奉在治疗急性脑出血后脑水肿的疗效观察[J].北方药学,2015,12(7):70-71.
[11] 吴信真,李玄英,严兴福,等.依达拉奉对急性颅脑外伤手术患者的脑保护作用[J].实用医学杂志,2010,26(1):116-118.
[12] 李茂良,李明起,张毅.云克系列药品的特点和治疗原理[J].中华风湿病学杂志,2003,7:48-51.
[13] 薛秀青,郑健,苏成海.云克对D-半乳糖致衰老小鼠血清自由基的影响[J].标记免疫分析与临床,2014,12(21):718-721.
[14] 马向前,胡颖.桑叶总黄酮抗运动疲劳作用及相关机制研究[J].中国实验方剂学杂志,2013,19(11):216-219.
[15] 郭爱民,曹建民,朱静,等.菟丝子对大鼠抗运动性疲劳能力及脑组织自由基的影响[J].中国实验方剂学杂志,2013,19(9):274-277.
[16] 金涛.开颅手术后颅内感染的危险因素分析[J].中国社区医师,2013,24(2):171.
[17] 杨怀祖.前列腺素E在疼痛中的作用[J].医学信息,2014, 27(1):473.
[18] 肖壮,唐涛,孙先润,等.骨关节炎治疗药物的研究进展[J].中国药房,2016,27(35):5037-5040.
[19] 罗试计.辨证论治配合云克治疗类风湿性关节炎34例[J].陕西中医,2011,32(4):432-434.
[20] 田珈瑜,荣晓凤.锝(99Tc)亚甲基二膦酸盐注射液联合DMARDs治疗晚期类风湿关节炎的临床观察[J].中国药房,2017,28(2):240-242.
[21] 邢海波,李刚.依达拉奉多器官保护作用及其机制的研究新进展[J].中日友好医院学报,2006,20(5):305-307.
[22] 于乐,郝玢,李正民,等.骨巨细胞瘤辅助治疗的研究进展[J].中国医药导报,2016,13(6):66-68,81.